Related Experiment Video
Updated: Apr 27, 2026
07:30
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
2.6K
Vascular cognitive impairment in dementia
1Western Australian Centre for Health & Ageing (M573), Centre for Medical Research, University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia; Department of Geriatric Medicine, Royal Perth Hospital, 197 Wellington Street, Perth, WA 6000, Australia.
Maturitas
|July 12, 2014
Summary
Vascular risk factors contribute to dementia, particularly vascular dementia. Understanding shared causes and co-occurrence with Alzheimer's disease is key for managing cognitive impairment in older adults.
Area of Science:
- Geriatrics
- Neurology
- Vascular Medicine
Background:
- Vascular risk factors and cerebrovascular disease are primary drivers of dementia.
- Shared etiologies and frequent co-pathology between vascular dementia and Alzheimer's disease suggest converging management strategies.
- Cognitive impairment linked to cerebrovascular disease is a growing concern in geriatric medicine.
Purpose of the Study:
- To highlight the significance of cognitive impairment associated with cerebrovascular disease in older populations.
- To emphasize the increasing burden of brain vascular disease due to population aging.
- To underscore the importance of diagnosis and intervention for improving clinical outcomes.
Main Methods:
- Review of current understanding of cerebrovascular disease and cognitive impairment.
- Analysis of clinical and imaging findings associated with cerebrovascular disease in older adults.
- Evaluation of evidence for prevention, lifestyle interventions, and secondary prevention strategies.
Main Results:
- A spectrum of cognitive disorders related to cerebrovascular disease is now recognized.
- Cerebrovascular disease in older individuals presents with distinct clinical and imaging characteristics.
- Prevention and risk factor control are crucial, though evidence for specific pharmacological interventions is limited.
Conclusions:
- Diagnosis of brain vascular disease is vital for improving patient outcomes through targeted interventions.
- Enhanced control of vascular risk factors and lifestyle modifications are central to managing cognitive decline.
- Further research is needed to build a stronger evidence base for pharmacological treatments in cognitive impairment due to cerebrovascular disease.
Related Concept Videos
01:22Dementia l: Introduction
29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
01:30Dementia
685
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
685
01:29Alzheimer Disease l: Introduction
19
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:30Cognitive Development During Adulthood
1.4K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K
01:23Alzheimer Disease ll: Pathophysiology
27
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
27